

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 9.83521279 |
| 2 | locomotory exploration behavior (GO:0035641) | 9.41675539 |
| 3 | gonadal mesoderm development (GO:0007506) | 8.36483986 |
| 4 | activated T cell proliferation (GO:0050798) | 7.71962249 |
| 5 | dermatan sulfate biosynthetic process (GO:0030208) | 7.17703246 |
| 6 | amino acid import (GO:0043090) | 6.84365655 |
| 7 | regulation of neuron projection regeneration (GO:0070570) | 6.61159951 |
| 8 | regulation of axon regeneration (GO:0048679) | 6.61159951 |
| 9 | dermatan sulfate metabolic process (GO:0030205) | 6.57260223 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 6.49784471 |
| 11 | presynaptic membrane assembly (GO:0097105) | 6.42855651 |
| 12 | regulation of transmission of nerve impulse (GO:0051969) | 6.38394932 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.20475274 |
| 14 | protein carboxylation (GO:0018214) | 5.97794782 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.97794782 |
| 16 | plasma lipoprotein particle assembly (GO:0034377) | 5.94424751 |
| 17 | regulation of fibrinolysis (GO:0051917) | 5.86633738 |
| 18 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 5.81153090 |
| 19 | chondroitin sulfate catabolic process (GO:0030207) | 5.79281504 |
| 20 | regulation of cholesterol esterification (GO:0010872) | 5.79165988 |
| 21 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.77484876 |
| 22 | plasma lipoprotein particle remodeling (GO:0034369) | 5.71692726 |
| 23 | protein-lipid complex remodeling (GO:0034368) | 5.71692726 |
| 24 | macromolecular complex remodeling (GO:0034367) | 5.71692726 |
| 25 | L-amino acid import (GO:0043092) | 5.69613075 |
| 26 | exploration behavior (GO:0035640) | 5.62298894 |
| 27 | postsynaptic membrane organization (GO:0001941) | 5.61237726 |
| 28 | protein-lipid complex assembly (GO:0065005) | 5.50576206 |
| 29 | low-density lipoprotein particle remodeling (GO:0034374) | 5.48987047 |
| 30 | cholesterol efflux (GO:0033344) | 5.46543398 |
| 31 | negative regulation of sterol transport (GO:0032372) | 5.44936683 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 5.44936683 |
| 33 | presynaptic membrane organization (GO:0097090) | 5.33690166 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 5.13573068 |
| 35 | plasma lipoprotein particle organization (GO:0071827) | 5.07999819 |
| 36 | intestinal cholesterol absorption (GO:0030299) | 5.05722989 |
| 37 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 5.05203555 |
| 38 | positive regulation of triglyceride lipase activity (GO:0061365) | 5.02758036 |
| 39 | positive regulation of lipoprotein lipase activity (GO:0051006) | 5.02758036 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.96644132 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.90755640 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 4.90755640 |
| 43 | phospholipid efflux (GO:0033700) | 4.89459840 |
| 44 | regulation of protein activation cascade (GO:2000257) | 4.89389850 |
| 45 | protein-lipid complex subunit organization (GO:0071825) | 4.89320305 |
| 46 | long-term synaptic potentiation (GO:0060291) | 4.84395757 |
| 47 | positive regulation of neurological system process (GO:0031646) | 4.81016072 |
| 48 | complement activation, alternative pathway (GO:0006957) | 4.78763712 |
| 49 | response to methylmercury (GO:0051597) | 4.76272536 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.74328105 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.73093787 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 4.73093787 |
| 53 | regulation of complement activation (GO:0030449) | 4.70211608 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 4.65990903 |
| 55 | proline metabolic process (GO:0006560) | 4.53504523 |
| 56 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.52750332 |
| 57 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.38515022 |
| 58 | astrocyte differentiation (GO:0048708) | 4.37899330 |
| 59 | regulation of plasminogen activation (GO:0010755) | 4.33303683 |
| 60 | oligodendrocyte differentiation (GO:0048709) | 4.26464231 |
| 61 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 4.18132878 |
| 62 | regulation of bile acid biosynthetic process (GO:0070857) | 4.17360773 |
| 63 | acute-phase response (GO:0006953) | 4.13624582 |
| 64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.08458622 |
| 65 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.06751017 |
| 66 | vocalization behavior (GO:0071625) | 4.05644160 |
| 67 | glutamate metabolic process (GO:0006536) | 4.05200510 |
| 68 | transmission of nerve impulse (GO:0019226) | 4.03886050 |
| 69 | sulfation (GO:0051923) | 4.03743180 |
| 70 | diacylglycerol metabolic process (GO:0046339) | 4.01539890 |
| 71 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.99373650 |
| 72 | regulation of apoptotic cell clearance (GO:2000425) | 3.98939335 |
| 73 | C4-dicarboxylate transport (GO:0015740) | 3.97180295 |
| 74 | cellular response to epinephrine stimulus (GO:0071872) | 3.96566300 |
| 75 | blood coagulation, intrinsic pathway (GO:0007597) | 3.95300303 |
| 76 | epoxygenase P450 pathway (GO:0019373) | 3.92580216 |
| 77 | vitamin A metabolic process (GO:0006776) | 3.92333098 |
| 78 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.87969753 |
| 79 | fibrinolysis (GO:0042730) | 3.85865326 |
| 80 | central nervous system myelination (GO:0022010) | 3.83612449 |
| 81 | axon ensheathment in central nervous system (GO:0032291) | 3.83612449 |
| 82 | intestinal absorption (GO:0050892) | 3.79830851 |
| 83 | dendrite morphogenesis (GO:0048813) | 3.79499523 |
| 84 | positive regulation of extracellular matrix organization (GO:1903055) | 3.75998854 |
| 85 | lipoprotein metabolic process (GO:0042157) | 3.72765160 |
| 86 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.69897618 |
| 87 | myelination (GO:0042552) | 3.68143072 |
| 88 | ethanol oxidation (GO:0006069) | 3.66413361 |
| 89 | negative regulation of axon extension (GO:0030517) | 3.65732945 |
| 90 | neuron recognition (GO:0008038) | 3.64774400 |
| 91 | acylglycerol homeostasis (GO:0055090) | 3.61975460 |
| 92 | triglyceride homeostasis (GO:0070328) | 3.61975460 |
| 93 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.60935875 |
| 94 | regulation of triglyceride catabolic process (GO:0010896) | 3.59797196 |
| 95 | negative regulation of blood coagulation (GO:0030195) | 3.55587216 |
| 96 | negative regulation of hemostasis (GO:1900047) | 3.55587216 |
| 97 | positive regulation of lipid catabolic process (GO:0050996) | 3.54133487 |
| 98 | axon ensheathment (GO:0008366) | 3.52165045 |
| 99 | ensheathment of neurons (GO:0007272) | 3.52165045 |
| 100 | response to epinephrine (GO:0071871) | 3.51760830 |
| 101 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50919224 |
| 102 | urea metabolic process (GO:0019627) | 3.49933284 |
| 103 | positive regulation of steroid metabolic process (GO:0045940) | 3.48733104 |
| 104 | collecting duct development (GO:0072044) | 3.47869660 |
| 105 | respiratory tube development (GO:0030323) | 3.46836279 |
| 106 | regulation of extracellular matrix organization (GO:1903053) | 3.46757906 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.46365139 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.46035005 |
| 109 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.43595278 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43112622 |
| 111 | myelination in peripheral nervous system (GO:0022011) | 3.41591476 |
| 112 | peripheral nervous system axon ensheathment (GO:0032292) | 3.41591476 |
| 113 | sterol homeostasis (GO:0055092) | 3.40505371 |
| 114 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.36562493 |
| 115 | regulation of timing of cell differentiation (GO:0048505) | 3.35295472 |
| 116 | sterol transport (GO:0015918) | 3.33806004 |
| 117 | cholesterol transport (GO:0030301) | 3.33806004 |
| 118 | positive regulation of hemostasis (GO:1900048) | 3.32786975 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 3.32786975 |
| 120 | negative regulation of lipid transport (GO:0032369) | 3.32746738 |
| 121 | urea cycle (GO:0000050) | 3.31853654 |
| 122 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.29929606 |
| 123 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.29843236 |
| 124 | protein activation cascade (GO:0072376) | 3.29064903 |
| 125 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.26734599 |
| 126 | detection of mechanical stimulus (GO:0050982) | 3.26620592 |
| 127 | aromatic amino acid family catabolic process (GO:0009074) | 3.26297888 |
| 128 | regulation of extracellular matrix disassembly (GO:0010715) | 3.23882542 |
| 129 | cerebellar granule cell differentiation (GO:0021707) | 3.22798525 |
| 130 | regulation of cholesterol metabolic process (GO:0090181) | 3.20827835 |
| 131 | membrane assembly (GO:0071709) | 3.17988840 |
| 132 | negative regulation of coagulation (GO:0050819) | 3.17751554 |
| 133 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.16780157 |
| 134 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.16435788 |
| 135 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.13538853 |
| 136 | response to hepatocyte growth factor (GO:0035728) | 3.13538853 |
| 137 | glutamate receptor signaling pathway (GO:0007215) | 3.13479632 |
| 138 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.13142413 |
| 139 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12570282 |
| 140 | regulation of platelet aggregation (GO:0090330) | 3.12517129 |
| 141 | regulation of axon guidance (GO:1902667) | 3.12345950 |
| 142 | nitrogen cycle metabolic process (GO:0071941) | 3.11288313 |
| 143 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.11073438 |
| 144 | negative regulation of myoblast differentiation (GO:0045662) | 3.10343917 |
| 145 | negative regulation of platelet activation (GO:0010544) | 3.10234384 |
| 146 | ethanol metabolic process (GO:0006067) | 3.09329831 |
| 147 | negative regulation of lipase activity (GO:0060192) | 3.07676295 |
| 148 | startle response (GO:0001964) | 3.07663450 |
| 149 | positive regulation of coagulation (GO:0050820) | 3.07651716 |
| 150 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.07578464 |
| 151 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.04162714 |
| 152 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.04162714 |
| 153 | righting reflex (GO:0060013) | 3.02004925 |
| 154 | opioid receptor signaling pathway (GO:0038003) | 3.01793312 |
| 155 | negative regulation of wound healing (GO:0061045) | 3.01669415 |
| 156 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.01253668 |
| 157 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.00170744 |
| 158 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.99099504 |
| 159 | glycerophospholipid catabolic process (GO:0046475) | 2.99002283 |
| 160 | lymphoid progenitor cell differentiation (GO:0002320) | 2.98589029 |
| 161 | positive regulation of synapse assembly (GO:0051965) | 2.97913165 |
| 162 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.97685046 |
| 163 | exogenous drug catabolic process (GO:0042738) | 2.96126177 |
| 164 | complement activation, classical pathway (GO:0006958) | 2.94908185 |
| 165 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.93815940 |
| 166 | auditory behavior (GO:0031223) | 2.91833299 |
| 167 | negative regulation of synaptic transmission (GO:0050805) | 2.91750762 |
| 168 | regulation of humoral immune response (GO:0002920) | 2.91672700 |
| 169 | glyoxylate metabolic process (GO:0046487) | 2.91555993 |
| 170 | low-density lipoprotein particle clearance (GO:0034383) | 2.90052800 |
| 171 | complement activation (GO:0006956) | 2.88486621 |
| 172 | chondroitin sulfate metabolic process (GO:0030204) | 2.88483258 |
| 173 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.87371302 |
| 174 | synaptic transmission, glutamatergic (GO:0035249) | 2.86074751 |
| 175 | acute inflammatory response (GO:0002526) | 2.84820964 |
| 176 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.84007953 |
| 177 | proline biosynthetic process (GO:0006561) | 2.83770646 |
| 178 | lipid homeostasis (GO:0055088) | 2.83725044 |
| 179 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.83138882 |
| 180 | prepulse inhibition (GO:0060134) | 2.82328933 |
| 181 | regulation of development, heterochronic (GO:0040034) | 2.82222571 |
| 182 | drug catabolic process (GO:0042737) | 2.80871997 |
| 183 | dendritic spine morphogenesis (GO:0060997) | 2.79985132 |
| 184 | pinocytosis (GO:0006907) | 2.78482024 |
| 185 | response to auditory stimulus (GO:0010996) | 2.76398507 |
| 186 | imidazole-containing compound metabolic process (GO:0052803) | 2.73726579 |
| 187 | bile acid metabolic process (GO:0008206) | 2.73368884 |
| 188 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.73145241 |
| 189 | retina layer formation (GO:0010842) | 2.72070773 |
| 190 | glial cell differentiation (GO:0010001) | 2.71736031 |
| 191 | protein localization to synapse (GO:0035418) | 2.71323907 |
| 192 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.70447529 |
| 193 | synapse assembly (GO:0007416) | 2.70011961 |
| 194 | axonal fasciculation (GO:0007413) | 2.67899714 |
| 195 | synapse organization (GO:0050808) | 2.67766404 |
| 196 | negative regulation of protein localization to cell surface (GO:2000009) | 2.65723174 |
| 197 | ovulation cycle (GO:0042698) | 2.65601983 |
| 198 | regulation of respiratory system process (GO:0044065) | 2.65371776 |
| 199 | regulation of glomerulus development (GO:0090192) | 2.61033325 |
| 200 | neuromuscular process controlling balance (GO:0050885) | 2.60921603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.37105540 |
| 2 | AR_21572438_ChIP-Seq_LNCaP_Human | 4.09774379 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05781867 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.61616138 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.52668626 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43791061 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.22134879 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12468968 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07815011 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94545278 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.86449002 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.86245944 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.79210383 |
| 14 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.58411535 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58048825 |
| 16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.55289540 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.50592400 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.50592400 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41783464 |
| 20 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.40224255 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39885376 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39618971 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36480351 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32829292 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.29825055 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.25921118 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.23099693 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.21536192 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19591993 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.14320281 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.11197929 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09187233 |
| 33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.08605223 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08371911 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06041255 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.05636678 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.04332299 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02073844 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00396708 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.99499150 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.98326705 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94187197 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91151954 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.84639285 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.83371947 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.79991368 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79052668 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.78420281 |
| 49 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72620448 |
| 50 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.71257865 |
| 51 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66835972 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65780847 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64790684 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64580458 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62957033 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.62260211 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60638321 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59365471 |
| 59 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.59364394 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54903392 |
| 61 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54873412 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52923915 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52725658 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.52525437 |
| 65 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.51641624 |
| 66 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51634238 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51303169 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50619059 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50370645 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.49749716 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47634973 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45793890 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42536096 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41520202 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.41216273 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41028686 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40914645 |
| 78 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39014312 |
| 79 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.35444013 |
| 80 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35409580 |
| 81 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34873447 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.34302369 |
| 83 | MYC_22102868_ChIP-Seq_BL_Human | 1.34042392 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33725993 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33552899 |
| 86 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33390790 |
| 87 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33115279 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33029257 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32189240 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32161938 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31139365 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30891208 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30550970 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30238102 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29899049 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.29283093 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.29236700 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.29180150 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28527976 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28413546 |
| 101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27563503 |
| 102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27193973 |
| 103 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26888401 |
| 104 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26196841 |
| 105 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26113001 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25831267 |
| 107 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24968752 |
| 108 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22012167 |
| 109 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21820481 |
| 110 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21820481 |
| 111 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21820481 |
| 112 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21792186 |
| 113 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21790441 |
| 114 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20116077 |
| 115 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19294652 |
| 116 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18685470 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18104346 |
| 118 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16634855 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15910456 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15862411 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15167262 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14889759 |
| 123 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.14855290 |
| 124 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14312249 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14289325 |
| 126 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.13409511 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13409511 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13240876 |
| 129 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12573432 |
| 130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12573432 |
| 131 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12533254 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12147708 |
| 133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11265212 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11189611 |
| 135 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10718946 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.10474808 |
| 137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10109106 |
| 138 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10102092 |
| 139 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09983263 |
| 140 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09692598 |
| 141 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09502251 |
| 142 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09267190 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08543335 |
| 144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08481963 |
| 145 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08092391 |
| 146 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07697467 |
| 147 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07514469 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07294875 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07293709 |
| 150 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06676429 |
| 151 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06634568 |
| 152 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06431363 |
| 153 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06428751 |
| 154 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06152634 |
| 155 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05789970 |
| 156 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05771483 |
| 157 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.05281857 |
| 158 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04744855 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04384714 |
| 160 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04354182 |
| 161 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04211921 |
| 162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03862226 |
| 163 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03196195 |
| 164 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03179695 |
| 165 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03043150 |
| 166 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02694860 |
| 167 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01672560 |
| 168 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00429854 |
| 169 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00270320 |
| 170 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99944068 |
| 171 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98836528 |
| 172 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98796185 |
| 173 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97990200 |
| 174 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97738793 |
| 175 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97071814 |
| 176 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96862805 |
| 177 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.96601810 |
| 178 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96386575 |
| 179 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95665914 |
| 180 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.95044081 |
| 181 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93647396 |
| 182 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93378437 |
| 183 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93268161 |
| 184 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91672152 |
| 185 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90732953 |
| 186 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.88639228 |
| 187 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87499003 |
| 188 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87192944 |
| 189 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86545889 |
| 190 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85633671 |
| 191 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.85186388 |
| 192 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83864646 |
| 193 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83063686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.39091046 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.07384656 |
| 3 | MP0003880_abnormal_central_pattern | 5.13382322 |
| 4 | MP0005365_abnormal_bile_salt | 4.74745144 |
| 5 | MP0005257_abnormal_intraocular_pressure | 4.03282616 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.83859756 |
| 7 | MP0004742_abnormal_vestibular_system | 3.78274266 |
| 8 | MP0009840_abnormal_foam_cell | 3.70041639 |
| 9 | MP0003195_calcinosis | 3.66762420 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.62068729 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.46868885 |
| 12 | MP0003136_yellow_coat_color | 3.28435389 |
| 13 | MP0000920_abnormal_myelination | 3.27673699 |
| 14 | MP0010329_abnormal_lipoprotein_level | 3.12315379 |
| 15 | MP0001666_abnormal_nutrient_absorption | 3.05661999 |
| 16 | MP0003941_abnormal_skin_development | 3.01119825 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.97994002 |
| 18 | MP0005171_absent_coat_pigmentation | 2.84154879 |
| 19 | MP0005451_abnormal_body_composition | 2.80735958 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.56058963 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 2.35656080 |
| 22 | MP0001529_abnormal_vocalization | 2.35404048 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.32480917 |
| 24 | MP0001486_abnormal_startle_reflex | 2.30135758 |
| 25 | MP0000778_abnormal_nervous_system | 2.28476325 |
| 26 | MP0004858_abnormal_nervous_system | 2.25508983 |
| 27 | MP0009745_abnormal_behavioral_response | 2.25286144 |
| 28 | MP0002064_seizures | 2.24581961 |
| 29 | MP0003011_delayed_dark_adaptation | 2.22457128 |
| 30 | MP0003303_peritoneal_inflammation | 2.18908040 |
| 31 | MP0005646_abnormal_pituitary_gland | 2.18455669 |
| 32 | MP0003252_abnormal_bile_duct | 2.15026050 |
| 33 | MP0002272_abnormal_nervous_system | 2.09335324 |
| 34 | MP0003690_abnormal_glial_cell | 2.07233370 |
| 35 | MP0002736_abnormal_nociception_after | 2.02786888 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 2.01359941 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 2.00956855 |
| 38 | MP0001968_abnormal_touch/_nociception | 2.00891063 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.97296923 |
| 40 | MP0002063_abnormal_learning/memory/cond | 1.88515593 |
| 41 | MP0000462_abnormal_digestive_system | 1.83211561 |
| 42 | MP0000604_amyloidosis | 1.82161623 |
| 43 | MP0004270_analgesia | 1.82134641 |
| 44 | MP0003634_abnormal_glial_cell | 1.81212514 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.77101366 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.76787293 |
| 47 | MP0003436_decreased_susceptibility_to | 1.74721722 |
| 48 | MP0000609_abnormal_liver_physiology | 1.71937979 |
| 49 | * MP0002118_abnormal_lipid_homeostasis | 1.69955486 |
| 50 | MP0004142_abnormal_muscle_tone | 1.67229328 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.66157694 |
| 52 | MP0004134_abnormal_chest_morphology | 1.66034561 |
| 53 | MP0002184_abnormal_innervation | 1.65402824 |
| 54 | MP0003879_abnormal_hair_cell | 1.64903814 |
| 55 | MP0005332_abnormal_amino_acid | 1.63372915 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.63338823 |
| 57 | MP0000631_abnormal_neuroendocrine_gland | 1.57836202 |
| 58 | MP0004885_abnormal_endolymph | 1.56331713 |
| 59 | MP0001984_abnormal_olfaction | 1.54908244 |
| 60 | MP0003122_maternal_imprinting | 1.54581802 |
| 61 | MP0005409_darkened_coat_color | 1.53745036 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.52673646 |
| 63 | MP0003632_abnormal_nervous_system | 1.52322249 |
| 64 | MP0000955_abnormal_spinal_cord | 1.44848738 |
| 65 | MP0009384_cardiac_valve_regurgitation | 1.43368425 |
| 66 | MP0009046_muscle_twitch | 1.43312209 |
| 67 | MP0003075_altered_response_to | 1.40707189 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.40455009 |
| 69 | MP0003385_abnormal_body_wall | 1.37826380 |
| 70 | MP0000566_synostosis | 1.36117826 |
| 71 | MP0001661_extended_life_span | 1.34742377 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.32670131 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 1.31754139 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.28241323 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.26146154 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.21656395 |
| 77 | MP0005670_abnormal_white_adipose | 1.21189660 |
| 78 | MP0001958_emphysema | 1.18104711 |
| 79 | MP0000467_abnormal_esophagus_morphology | 1.16720434 |
| 80 | MP0001485_abnormal_pinna_reflex | 1.16625893 |
| 81 | MP0004019_abnormal_vitamin_homeostasis | 1.15916282 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.14751317 |
| 83 | MP0008569_lethality_at_weaning | 1.14087941 |
| 84 | MP0001905_abnormal_dopamine_level | 1.13874734 |
| 85 | MP0001970_abnormal_pain_threshold | 1.13374450 |
| 86 | MP0005367_renal/urinary_system_phenotyp | 1.12930697 |
| 87 | MP0000516_abnormal_urinary_system | 1.12930697 |
| 88 | MP0003938_abnormal_ear_development | 1.12897708 |
| 89 | MP0001501_abnormal_sleep_pattern | 1.12170230 |
| 90 | MP0005623_abnormal_meninges_morphology | 1.11883663 |
| 91 | MP0002132_abnormal_respiratory_system | 1.11527879 |
| 92 | MP0000534_abnormal_ureter_morphology | 1.10130384 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 1.10095839 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 1.08255229 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 1.07843196 |
| 96 | MP0009278_abnormal_bone_marrow | 1.06141856 |
| 97 | MP0003329_amyloid_beta_deposits | 1.05947528 |
| 98 | MP0002090_abnormal_vision | 1.05396525 |
| 99 | MP0005666_abnormal_adipose_tissue | 1.04718096 |
| 100 | MP0002752_abnormal_somatic_nervous | 1.03503524 |
| 101 | MP0002152_abnormal_brain_morphology | 1.02927488 |
| 102 | MP0002282_abnormal_trachea_morphology | 1.02233241 |
| 103 | MP0001764_abnormal_homeostasis | 0.99821707 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.99596511 |
| 105 | MP0001853_heart_inflammation | 0.98591065 |
| 106 | MP0005166_decreased_susceptibility_to | 0.98476754 |
| 107 | MP0008469_abnormal_protein_level | 0.98422781 |
| 108 | MP0005464_abnormal_platelet_physiology | 0.97393408 |
| 109 | MP0001502_abnormal_circadian_rhythm | 0.96864759 |
| 110 | MP0000733_abnormal_muscle_development | 0.96550138 |
| 111 | MP0001915_intracranial_hemorrhage | 0.95959925 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.95414388 |
| 113 | MP0003868_abnormal_feces_composition | 0.95410640 |
| 114 | MP0004510_myositis | 0.94466355 |
| 115 | MP0002735_abnormal_chemical_nociception | 0.94275994 |
| 116 | MP0009643_abnormal_urine_homeostasis | 0.94184591 |
| 117 | MP0010155_abnormal_intestine_physiology | 0.94020149 |
| 118 | MP0003631_nervous_system_phenotype | 0.93515395 |
| 119 | MP0002233_abnormal_nose_morphology | 0.92094864 |
| 120 | MP0000598_abnormal_liver_morphology | 0.91986266 |
| 121 | MP0000026_abnormal_inner_ear | 0.91869626 |
| 122 | MP0003045_fibrosis | 0.91839633 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89212229 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.86249150 |
| 125 | MP0005636_abnormal_mineral_homeostasis | 0.83983957 |
| 126 | MP0009764_decreased_sensitivity_to | 0.83837931 |
| 127 | MP0005448_abnormal_energy_balance | 0.83063247 |
| 128 | MP0008260_abnormal_autophagy | 0.82786365 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.82017275 |
| 130 | MP0005195_abnormal_posterior_eye | 0.81696577 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.81635738 |
| 132 | MP0003123_paternal_imprinting | 0.81633388 |
| 133 | MP0005025_abnormal_response_to | 0.79941348 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.79742122 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.79610710 |
| 136 | MP0005410_abnormal_fertilization | 0.78501567 |
| 137 | MP0002971_abnormal_brown_adipose | 0.77980833 |
| 138 | MP0009115_abnormal_fat_cell | 0.76964085 |
| 139 | MP0003453_abnormal_keratinocyte_physiol | 0.76607979 |
| 140 | MP0001943_abnormal_respiration | 0.76284561 |
| 141 | MP0002419_abnormal_innate_immunity | 0.75739960 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.74928148 |
| 143 | MP0000858_altered_metastatic_potential | 0.74919017 |
| 144 | MP0000762_abnormal_tongue_morphology | 0.74679080 |
| 145 | MP0000249_abnormal_blood_vessel | 0.74288808 |
| 146 | MP0005386_behavior/neurological_phenoty | 0.73939232 |
| 147 | MP0004924_abnormal_behavior | 0.73939232 |
| 148 | MP0001765_abnormal_ion_homeostasis | 0.73568998 |
| 149 | MP0001293_anophthalmia | 0.73052793 |
| 150 | MP0002876_abnormal_thyroid_physiology | 0.72128258 |
| 151 | MP0003300_gastrointestinal_ulcer | 0.69713008 |
| 152 | MP0009785_altered_susceptibility_to | 0.69567516 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.67348977 |
| 154 | MP0003806_abnormal_nucleotide_metabolis | 0.67133709 |
| 155 | MP0002249_abnormal_larynx_morphology | 0.67089312 |
| 156 | MP0005535_abnormal_body_temperature | 0.66825312 |
| 157 | MP0004264_abnormal_extraembryonic_tissu | 0.66641369 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.66215982 |
| 159 | MP0001545_abnormal_hematopoietic_system | 0.66215982 |
| 160 | MP0004947_skin_inflammation | 0.65838819 |
| 161 | MP0002933_joint_inflammation | 0.65346756 |
| 162 | MP0003633_abnormal_nervous_system | 0.64821941 |
| 163 | MP0002148_abnormal_hypersensitivity_rea | 0.64124716 |
| 164 | MP0001177_atelectasis | 0.64070628 |
| 165 | MP0002229_neurodegeneration | 0.63408283 |
| 166 | MP0001340_abnormal_eyelid_morphology | 0.62630330 |
| 167 | MP0005377_hearing/vestibular/ear_phenot | 0.62498349 |
| 168 | MP0003878_abnormal_ear_physiology | 0.62498349 |
| 169 | MP0004043_abnormal_pH_regulation | 0.62476683 |
| 170 | MP0005388_respiratory_system_phenotype | 0.62275735 |
| 171 | MP0002133_abnormal_respiratory_system | 0.62275735 |
| 172 | * MP0003172_abnormal_lysosome_physiology | 0.61764650 |
| 173 | MP0003091_abnormal_cell_migration | 0.60275606 |
| 174 | MP0006082_CNS_inflammation | 0.59922557 |
| 175 | MP0002089_abnormal_postnatal_growth/wei | 0.59108882 |
| 176 | MP0005375_adipose_tissue_phenotype | 0.58591581 |
| 177 | MP0002116_abnormal_craniofacial_bone | 0.58222631 |
| 178 | MP0004381_abnormal_hair_follicle | 0.57769350 |
| 179 | MP0009763_increased_sensitivity_to | 0.57454084 |
| 180 | MP0000747_muscle_weakness | 0.56982757 |
| 181 | MP0005334_abnormal_fat_pad | 0.56981052 |
| 182 | MP0000678_abnormal_parathyroid_gland | 0.56727675 |
| 183 | MP0001756_abnormal_urination | 0.56576916 |
| 184 | MP0001845_abnormal_inflammatory_respons | 0.53758107 |
| 185 | MP0002166_altered_tumor_susceptibility | 0.52326449 |
| 186 | MP0004130_abnormal_muscle_cell | 0.51701621 |
| 187 | MP0003866_abnormal_defecation | 0.51622151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.08402741 |
| 2 | Joint hemorrhage (HP:0005261) | 6.25133731 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.16181141 |
| 4 | Complement deficiency (HP:0004431) | 5.94096778 |
| 5 | Absent speech (HP:0001344) | 5.69247120 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.66536099 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.40708084 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.30931610 |
| 9 | Hemorrhage of the eye (HP:0011885) | 5.27032574 |
| 10 | Epiphyseal dysplasia (HP:0002656) | 5.26794651 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 5.25751498 |
| 12 | Hyperventilation (HP:0002883) | 5.20890675 |
| 13 | Xanthomatosis (HP:0000991) | 5.10192646 |
| 14 | Microglossia (HP:0000171) | 4.89495131 |
| 15 | Abnormality of complement system (HP:0005339) | 4.75114092 |
| 16 | Glomerulonephritis (HP:0000099) | 4.46149271 |
| 17 | Delayed CNS myelination (HP:0002188) | 4.41469305 |
| 18 | Peripheral hypomyelination (HP:0007182) | 4.38322353 |
| 19 | Adrenal hypoplasia (HP:0000835) | 4.25679569 |
| 20 | Congenital sensorineural hearing impairment (HP:0008527) | 3.89126329 |
| 21 | Anophthalmia (HP:0000528) | 3.88292283 |
| 22 | Small epiphyses (HP:0010585) | 3.87676213 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81567379 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.80407306 |
| 25 | Hypolipoproteinemia (HP:0010981) | 3.75019736 |
| 26 | Blue irides (HP:0000635) | 3.57781096 |
| 27 | Hypoplasia of the iris (HP:0007676) | 3.51568076 |
| 28 | Alacrima (HP:0000522) | 3.47882399 |
| 29 | White forelock (HP:0002211) | 3.44746018 |
| 30 | Fetal akinesia sequence (HP:0001989) | 3.41162310 |
| 31 | Hyperlipoproteinemia (HP:0010980) | 3.34932655 |
| 32 | Patchy hypopigmentation of hair (HP:0011365) | 3.28756331 |
| 33 | Purpura (HP:0000979) | 3.25811220 |
| 34 | Broad-based gait (HP:0002136) | 3.25760940 |
| 35 | Morphological abnormality of the inner ear (HP:0011390) | 3.25686937 |
| 36 | Abnormality of the parathyroid morphology (HP:0011766) | 3.24161323 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 3.16141641 |
| 38 | Akinesia (HP:0002304) | 3.15558172 |
| 39 | Decreased lacrimation (HP:0000633) | 3.12921974 |
| 40 | Relative macrocephaly (HP:0004482) | 3.11653018 |
| 41 | Intrahepatic cholestasis (HP:0001406) | 3.10970653 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.04778642 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.04778642 |
| 44 | Neurofibrillary tangles (HP:0002185) | 3.04355123 |
| 45 | Abnormality of secondary sexual hair (HP:0009888) | 2.98800256 |
| 46 | Abnormality of the axillary hair (HP:0100134) | 2.98800256 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 2.98659049 |
| 48 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.93670109 |
| 49 | Myocardial infarction (HP:0001658) | 2.92323952 |
| 50 | Premature skin wrinkling (HP:0100678) | 2.90157291 |
| 51 | Amyloidosis (HP:0011034) | 2.89239186 |
| 52 | Spontaneous abortion (HP:0005268) | 2.88916733 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.81568480 |
| 54 | Mild short stature (HP:0003502) | 2.77300593 |
| 55 | Intention tremor (HP:0002080) | 2.76044624 |
| 56 | Bifid scrotum (HP:0000048) | 2.75451230 |
| 57 | Septo-optic dysplasia (HP:0100842) | 2.71750556 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62489231 |
| 59 | Menorrhagia (HP:0000132) | 2.58550283 |
| 60 | Focal motor seizures (HP:0011153) | 2.58324133 |
| 61 | Sensory axonal neuropathy (HP:0003390) | 2.57574049 |
| 62 | Fat malabsorption (HP:0002630) | 2.54991076 |
| 63 | Abnormality of the corticospinal tract (HP:0002492) | 2.53978738 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49878241 |
| 65 | Epidermoid cyst (HP:0200040) | 2.49053584 |
| 66 | Gingival bleeding (HP:0000225) | 2.47866481 |
| 67 | Cupped ear (HP:0000378) | 2.47077458 |
| 68 | Abnormality of the lumbar spine (HP:0100712) | 2.46908826 |
| 69 | Broad ribs (HP:0000885) | 2.45172560 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.44412582 |
| 71 | Drooling (HP:0002307) | 2.41946812 |
| 72 | Excessive salivation (HP:0003781) | 2.41946812 |
| 73 | Hemiparesis (HP:0001269) | 2.38878789 |
| 74 | Nephritis (HP:0000123) | 2.38532119 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36784194 |
| 76 | Mucopolysacchariduria (HP:0008155) | 2.36784194 |
| 77 | Exercise-induced myalgia (HP:0003738) | 2.34913436 |
| 78 | Flat acetabular roof (HP:0003180) | 2.34617917 |
| 79 | Flared iliac wings (HP:0002869) | 2.34253529 |
| 80 | Abnormal auditory evoked potentials (HP:0006958) | 2.29000292 |
| 81 | Myokymia (HP:0002411) | 2.28888605 |
| 82 | Generalized myoclonic seizures (HP:0002123) | 2.27273147 |
| 83 | Heterochromia iridis (HP:0001100) | 2.27160573 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26345749 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26345749 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26345749 |
| 87 | Vascular calcification (HP:0004934) | 2.26173139 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.25323365 |
| 89 | Optic nerve hypoplasia (HP:0000609) | 2.24973421 |
| 90 | Thrombophlebitis (HP:0004418) | 2.22941619 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 2.22266241 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 2.22204342 |
| 93 | Vaginal fistula (HP:0004320) | 2.20734911 |
| 94 | Mitral stenosis (HP:0001718) | 2.20592217 |
| 95 | Hydroxyprolinuria (HP:0003080) | 2.19428867 |
| 96 | Abnormality of proline metabolism (HP:0010907) | 2.19428867 |
| 97 | Abnormality of the Achilles tendon (HP:0005109) | 2.19101485 |
| 98 | Gastrointestinal stroma tumor (HP:0100723) | 2.18748016 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 2.16191632 |
| 100 | Rickets (HP:0002748) | 2.14625736 |
| 101 | Ankle clonus (HP:0011448) | 2.13783359 |
| 102 | Acanthocytosis (HP:0001927) | 2.12566779 |
| 103 | Anosmia (HP:0000458) | 2.12189067 |
| 104 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.11905431 |
| 105 | Retinal dysplasia (HP:0007973) | 2.11465872 |
| 106 | Skin nodule (HP:0200036) | 2.10790838 |
| 107 | Pulmonary embolism (HP:0002204) | 2.10475505 |
| 108 | Thin bony cortex (HP:0002753) | 2.09247849 |
| 109 | Abolished electroretinogram (ERG) (HP:0000550) | 2.06428929 |
| 110 | Spastic gait (HP:0002064) | 2.05741080 |
| 111 | Clumsiness (HP:0002312) | 2.05701299 |
| 112 | Pachygyria (HP:0001302) | 2.03865636 |
| 113 | Focal seizures (HP:0007359) | 2.02642917 |
| 114 | Widely spaced teeth (HP:0000687) | 2.01959671 |
| 115 | Diminished movement (HP:0002374) | 2.01854039 |
| 116 | Abnormality of the sella turcica (HP:0002679) | 2.00590881 |
| 117 | Scanning speech (HP:0002168) | 1.97010483 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.96386142 |
| 119 | Abnormality of the intrinsic pathway (HP:0010989) | 1.96339023 |
| 120 | Absent hand (HP:0004050) | 1.95592137 |
| 121 | Barrel-shaped chest (HP:0001552) | 1.94723213 |
| 122 | Increased serum ferritin (HP:0003281) | 1.94220257 |
| 123 | Severe muscular hypotonia (HP:0006829) | 1.92585186 |
| 124 | Pulmonic stenosis (HP:0001642) | 1.91477242 |
| 125 | Hepatocellular carcinoma (HP:0001402) | 1.89103519 |
| 126 | Cortical dysplasia (HP:0002539) | 1.88899642 |
| 127 | Dysmetria (HP:0001310) | 1.87253488 |
| 128 | Facial shape deformation (HP:0011334) | 1.86214567 |
| 129 | Potter facies (HP:0002009) | 1.86214567 |
| 130 | Asymmetry of the thorax (HP:0001555) | 1.85743369 |
| 131 | Disproportionate short-trunk short stature (HP:0003521) | 1.84812439 |
| 132 | Pulmonary artery stenosis (HP:0004415) | 1.84770656 |
| 133 | Polygenic inheritance (HP:0010982) | 1.84615321 |
| 134 | Flat face (HP:0012368) | 1.84478837 |
| 135 | Chin dimple (HP:0010751) | 1.83876834 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.83124090 |
| 137 | Cardiovascular calcification (HP:0011915) | 1.83015304 |
| 138 | Epileptic encephalopathy (HP:0200134) | 1.82897316 |
| 139 | Abnormality of salivation (HP:0100755) | 1.82149805 |
| 140 | Preauricular pit (HP:0004467) | 1.81092946 |
| 141 | Periauricular skin pits (HP:0100277) | 1.81092946 |
| 142 | Irregular epiphyses (HP:0010582) | 1.80660078 |
| 143 | Poor suck (HP:0002033) | 1.78098325 |
| 144 | Proximal placement of thumb (HP:0009623) | 1.77905586 |
| 145 | Adactyly (HP:0009776) | 1.77834008 |
| 146 | Submucous cleft hard palate (HP:0000176) | 1.77498042 |
| 147 | Delayed myelination (HP:0012448) | 1.77365858 |
| 148 | Hypoplasia of the odontoid process (HP:0003311) | 1.75368587 |
| 149 | Pigmentary retinal degeneration (HP:0001146) | 1.74801655 |
| 150 | Hypophosphatemia (HP:0002148) | 1.73089764 |
| 151 | Retrobulbar optic neuritis (HP:0100654) | 1.72882291 |
| 152 | Optic neuritis (HP:0100653) | 1.72882291 |
| 153 | Abnormality of glycine metabolism (HP:0010895) | 1.72584679 |
| 154 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72584679 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.71221280 |
| 156 | Spastic tetraplegia (HP:0002510) | 1.71116235 |
| 157 | Gastroesophageal reflux (HP:0002020) | 1.70875244 |
| 158 | Orchitis (HP:0100796) | 1.70809230 |
| 159 | Gangrene (HP:0100758) | 1.70779343 |
| 160 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.70623147 |
| 161 | Febrile seizures (HP:0002373) | 1.70612683 |
| 162 | Atonic seizures (HP:0010819) | 1.69629176 |
| 163 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.68240218 |
| 164 | Metabolic alkalosis (HP:0200114) | 1.67779766 |
| 165 | Abnormal ossification of hand bones (HP:0005921) | 1.67353916 |
| 166 | Seborrheic dermatitis (HP:0001051) | 1.67337033 |
| 167 | Fair hair (HP:0002286) | 1.66899383 |
| 168 | Postural instability (HP:0002172) | 1.66836522 |
| 169 | Oligodactyly (hands) (HP:0001180) | 1.66734248 |
| 170 | Hyperglycinuria (HP:0003108) | 1.66583441 |
| 171 | Lower limb muscle weakness (HP:0007340) | 1.66182837 |
| 172 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66113407 |
| 173 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.65199072 |
| 174 | Abnormal tarsal ossification (HP:0008369) | 1.64976377 |
| 175 | Increased cerebral lipofuscin (HP:0011813) | 1.64785325 |
| 176 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.64536278 |
| 177 | Enlarged epiphyses (HP:0010580) | 1.63633278 |
| 178 | Late onset (HP:0003584) | 1.63490200 |
| 179 | Abnormality of the thoracic spine (HP:0100711) | 1.63160122 |
| 180 | Abnormality of the periventricular white matter (HP:0002518) | 1.61834205 |
| 181 | Generalized aminoaciduria (HP:0002909) | 1.59403656 |
| 182 | Epistaxis (HP:0000421) | 1.57179918 |
| 183 | Elevated alkaline phosphatase (HP:0003155) | 1.56812637 |
| 184 | Protuberant abdomen (HP:0001538) | 1.56527471 |
| 185 | Bronchomalacia (HP:0002780) | 1.56262359 |
| 186 | Abnormality of iron homeostasis (HP:0011031) | 1.55254997 |
| 187 | Steatorrhea (HP:0002570) | 1.54927636 |
| 188 | Hyperammonemia (HP:0001987) | 1.54762656 |
| 189 | Mesangial abnormality (HP:0001966) | 1.54152536 |
| 190 | Abnormal hand bone ossification (HP:0010660) | 1.53975047 |
| 191 | Abnormality of glycolipid metabolism (HP:0010969) | 1.53326448 |
| 192 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.53326448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 6.93825360 |
| 2 | FES | 5.81377133 |
| 3 | TYRO3 | 5.74149234 |
| 4 | FGFR4 | 5.41846504 |
| 5 | TNIK | 4.63049887 |
| 6 | TRIB3 | 3.24274417 |
| 7 | RIPK1 | 3.21779257 |
| 8 | IRAK3 | 2.86388239 |
| 9 | ERN1 | 2.56196704 |
| 10 | FGFR3 | 2.49923128 |
| 11 | NTRK3 | 2.49498231 |
| 12 | PDGFRB | 2.43283372 |
| 13 | NEK6 | 2.36292189 |
| 14 | ICK | 2.31416293 |
| 15 | EPHA4 | 1.97744633 |
| 16 | CDK12 | 1.96213996 |
| 17 | PHKG2 | 1.95028848 |
| 18 | PHKG1 | 1.95028848 |
| 19 | CSK | 1.83461306 |
| 20 | PDGFRA | 1.82777263 |
| 21 | DYRK1B | 1.75929544 |
| 22 | MATK | 1.68477343 |
| 23 | IRAK2 | 1.64616638 |
| 24 | NTRK2 | 1.54872994 |
| 25 | MARK1 | 1.50211925 |
| 26 | EEF2K | 1.47153645 |
| 27 | MAP2K3 | 1.46863375 |
| 28 | PBK | 1.40656529 |
| 29 | MAP3K11 | 1.31762500 |
| 30 | EPHB1 | 1.28040602 |
| 31 | IRAK1 | 1.27364251 |
| 32 | MAPK13 | 1.25650287 |
| 33 | PKN2 | 1.20708565 |
| 34 | PKN1 | 1.20495335 |
| 35 | ERBB3 | 1.17416791 |
| 36 | GRK7 | 1.16646201 |
| 37 | MAP3K1 | 1.15958080 |
| 38 | TAOK2 | 1.15255380 |
| 39 | WNK4 | 1.14891086 |
| 40 | TBK1 | 1.12525734 |
| 41 | IRAK4 | 1.12341018 |
| 42 | MAPK11 | 1.10437433 |
| 43 | MAPK15 | 1.08676587 |
| 44 | MAP3K7 | 1.02336547 |
| 45 | MAP3K4 | 1.01277150 |
| 46 | PIK3CA | 1.00464933 |
| 47 | NTRK1 | 0.99928655 |
| 48 | MAP3K14 | 0.98446553 |
| 49 | MAP4K1 | 0.94543051 |
| 50 | TAOK1 | 0.94421313 |
| 51 | BLK | 0.93389183 |
| 52 | STK39 | 0.93007768 |
| 53 | ZAP70 | 0.90533628 |
| 54 | SMG1 | 0.89667505 |
| 55 | PDK1 | 0.89006601 |
| 56 | MAPKAPK5 | 0.87751790 |
| 57 | FGR | 0.87624822 |
| 58 | MAP2K6 | 0.86534886 |
| 59 | MAP3K3 | 0.86526425 |
| 60 | TYK2 | 0.82778916 |
| 61 | MAPK12 | 0.78893138 |
| 62 | MAPK7 | 0.77624586 |
| 63 | OXSR1 | 0.77468931 |
| 64 | CHUK | 0.77354471 |
| 65 | ROCK1 | 0.75336978 |
| 66 | ERBB4 | 0.75275800 |
| 67 | SIK1 | 0.74512916 |
| 68 | GRK1 | 0.74096344 |
| 69 | INSR | 0.72799071 |
| 70 | PTK6 | 0.71508348 |
| 71 | DDR2 | 0.71325065 |
| 72 | DAPK2 | 0.70635796 |
| 73 | SGK3 | 0.69540630 |
| 74 | MST1R | 0.68462315 |
| 75 | WNK3 | 0.68383611 |
| 76 | ROCK2 | 0.67743839 |
| 77 | FYN | 0.67474700 |
| 78 | CAMK1D | 0.67402362 |
| 79 | BMX | 0.66760953 |
| 80 | GSK3A | 0.65028582 |
| 81 | STK24 | 0.64181918 |
| 82 | SIK2 | 0.63830237 |
| 83 | PNCK | 0.63221274 |
| 84 | YES1 | 0.61962387 |
| 85 | PRKCQ | 0.61570445 |
| 86 | CDK5 | 0.61121388 |
| 87 | MAP3K2 | 0.60811993 |
| 88 | LCK | 0.60624359 |
| 89 | RET | 0.59901319 |
| 90 | MTOR | 0.59271067 |
| 91 | NME1 | 0.59220512 |
| 92 | KSR2 | 0.58082120 |
| 93 | IKBKB | 0.57720508 |
| 94 | UHMK1 | 0.57239372 |
| 95 | ADRBK2 | 0.56752321 |
| 96 | CDK6 | 0.56176055 |
| 97 | RIPK4 | 0.56030981 |
| 98 | SGK2 | 0.54084170 |
| 99 | MAP2K2 | 0.53326256 |
| 100 | CAMK1G | 0.52971897 |
| 101 | PRKACG | 0.52327859 |
| 102 | CSF1R | 0.52259611 |
| 103 | MUSK | 0.52083646 |
| 104 | CAMK4 | 0.51688016 |
| 105 | LYN | 0.51172416 |
| 106 | PRPF4B | 0.51039453 |
| 107 | MINK1 | 0.50667756 |
| 108 | LIMK1 | 0.50120244 |
| 109 | PRKAA1 | 0.49999074 |
| 110 | ERBB2 | 0.48696049 |
| 111 | CAMKK1 | 0.47905412 |
| 112 | PTK2 | 0.47876071 |
| 113 | GRK6 | 0.47330823 |
| 114 | ABL2 | 0.46856091 |
| 115 | EPHB2 | 0.46134680 |
| 116 | SRC | 0.45927458 |
| 117 | CAMK2A | 0.45095152 |
| 118 | RPS6KA3 | 0.44522982 |
| 119 | PLK2 | 0.43400303 |
| 120 | TNK2 | 0.43260180 |
| 121 | IKBKE | 0.41664532 |
| 122 | FGFR1 | 0.41092873 |
| 123 | HIPK2 | 0.41006404 |
| 124 | MAPK10 | 0.40447264 |
| 125 | PDK2 | 0.40104103 |
| 126 | PRKG2 | 0.40082681 |
| 127 | ALK | 0.40068314 |
| 128 | IGF1R | 0.39435112 |
| 129 | PRKCG | 0.39244872 |
| 130 | PRKAA2 | 0.39046679 |
| 131 | PRKD3 | 0.37652503 |
| 132 | CDC42BPA | 0.37198272 |
| 133 | DMPK | 0.36650528 |
| 134 | MAP3K5 | 0.36298227 |
| 135 | PRKCE | 0.36250743 |
| 136 | PAK3 | 0.35713653 |
| 137 | LMTK2 | 0.35461485 |
| 138 | RPS6KB1 | 0.35033020 |
| 139 | JAK2 | 0.34942963 |
| 140 | STK11 | 0.34611381 |
| 141 | MARK2 | 0.34136880 |
| 142 | SGK1 | 0.34018274 |
| 143 | PAK6 | 0.33682885 |
| 144 | MAP2K7 | 0.33573578 |
| 145 | PRKACA | 0.32775341 |
| 146 | BMPR2 | 0.32466472 |
| 147 | WNK1 | 0.30993194 |
| 148 | MAP2K4 | 0.29640848 |
| 149 | CSNK1D | 0.29559022 |
| 150 | CDK3 | 0.29539168 |
| 151 | EIF2AK2 | 0.28573543 |
| 152 | CDK8 | 0.27710856 |
| 153 | PDPK1 | 0.26765670 |
| 154 | PRKG1 | 0.26529996 |
| 155 | PRKACB | 0.26164561 |
| 156 | SGK494 | 0.24970561 |
| 157 | SGK223 | 0.24970561 |
| 158 | ADRBK1 | 0.24222591 |
| 159 | HCK | 0.23994186 |
| 160 | BTK | 0.22946873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.21975564 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 4.19452987 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38396082 |
| 4 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 2.81875544 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.80336534 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75294259 |
| 7 | Prion diseases_Homo sapiens_hsa05020 | 2.63455169 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.58377574 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.52762873 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45377815 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.38871741 |
| 12 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.37580456 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.32619866 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.31709154 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 2.30134720 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.27341808 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.20405533 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.08419912 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.07444245 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.99910631 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.99757627 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.93566394 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.90453757 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.90154338 |
| 25 | * Other glycan degradation_Homo sapiens_hsa00511 | 1.88567491 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81195368 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.79816028 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74530526 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74004196 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.71432530 |
| 31 | Long-term depression_Homo sapiens_hsa04730 | 1.67362501 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66601702 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.64282284 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60001679 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.53400811 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.53136794 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.51403759 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51389419 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50581361 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50561120 |
| 41 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.49551155 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.49451491 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47839699 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.45605822 |
| 45 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45534097 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44792417 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43514759 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40073418 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36460152 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.36145320 |
| 51 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.35018947 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33430172 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.33033783 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32804479 |
| 55 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30468564 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29405933 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25896597 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24428394 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.23564604 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22699898 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.17174267 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16792276 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 1.16391735 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15299885 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14926812 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12909838 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12319055 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.10423813 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.08839083 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 1.04467101 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03182567 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00550067 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98901962 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98546098 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97280466 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97162820 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96680262 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95448021 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95128368 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93451541 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.92150133 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91855815 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.91551260 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90866277 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.87894544 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.86998171 |
| 87 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86605737 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85809457 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85274809 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84629948 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.84014763 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.83525872 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.82920437 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82736480 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82523317 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80169670 |
| 97 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79924676 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76893641 |
| 99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.75617282 |
| 100 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75375501 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73578782 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71425324 |
| 103 | Taste transduction_Homo sapiens_hsa04742 | 0.71082693 |
| 104 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.70173380 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67938116 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.67062454 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66694317 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65369261 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65366937 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64878959 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64243175 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63788963 |
| 113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63656902 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63626513 |
| 115 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61838156 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.61257626 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61231982 |
| 118 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.60289705 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.60192197 |
| 120 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58510887 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57006291 |
| 122 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56347835 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56149989 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55424820 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54521494 |
| 126 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53943203 |
| 127 | Phototransduction_Homo sapiens_hsa04744 | 0.53460327 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52984818 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52968020 |
| 130 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52456610 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51085053 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.50481757 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49494440 |
| 134 | Lysine degradation_Homo sapiens_hsa00310 | 0.49107333 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47920407 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47220468 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47152582 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.46962617 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45357325 |
| 140 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45331055 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43421751 |
| 142 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42784625 |
| 143 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42068433 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41695460 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41639433 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41423283 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41171814 |
| 148 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41119562 |
| 149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41077276 |
| 150 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40350415 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40253955 |
| 152 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40032753 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39648829 |
| 154 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38367133 |
| 155 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38101367 |
| 156 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37989936 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37261070 |
| 158 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37149439 |
| 159 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36403671 |
| 160 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35973571 |
| 161 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.35591222 |
| 162 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34261829 |
| 163 | Leishmaniasis_Homo sapiens_hsa05140 | 0.34216559 |
| 164 | Alzheimers disease_Homo sapiens_hsa05010 | 0.32419741 |
| 165 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32354712 |
| 166 | Bladder cancer_Homo sapiens_hsa05219 | 0.30907755 |
| 167 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28446649 |
| 168 | Amoebiasis_Homo sapiens_hsa05146 | 0.28113735 |
| 169 | Hepatitis C_Homo sapiens_hsa05160 | 0.25648376 |
| 170 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25341983 |
| 171 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24710766 |
| 172 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22326835 |
| 173 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19861214 |
| 174 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19704334 |
| 175 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.19520620 |
| 176 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.19453778 |
| 177 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.19363009 |

